0001209191-20-055030.txt : 20201016 0001209191-20-055030.hdr.sgml : 20201016 20201016152925 ACCESSION NUMBER: 0001209191-20-055030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201014 FILED AS OF DATE: 20201016 DATE AS OF CHANGE: 20201016 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BISCHOFBERGER NORBERT W CENTRAL INDEX KEY: 0001190273 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39592 FILM NUMBER: 201243887 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR STREET 2: C/O GILEAD SCIENCES, INC. CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kronos Bio, Inc. CENTRAL INDEX KEY: 0001741830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1300 S. EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: 212-871-7920 MAIL ADDRESS: STREET 1: 1300 S. EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN MATEO STATE: CA ZIP: 94402 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-14 0 0001741830 Kronos Bio, Inc. KRON 0001190273 BISCHOFBERGER NORBERT W C/O KRONOS BIO, INC. 1300 SO. EL CAMINO REAL, SUITE 300 SAN MATEO CA 94402 1 1 0 0 President & CEO Common Stock 2020-10-14 4 C 0 316501 A 2437662 I See footnote Common Stock 2020-10-14 4 C 0 1651576 A 4089238 I See footnote Common Stock 2020-10-14 4 C 0 185758 16.15 A 4274996 I See footnote Common Stock 2020-10-14 4 P 0 95500 19.00 A 4370496 I See footnote Common Stock 2020-10-14 4 C 0 263750 A 263750 I See footnote Common Stock 2020-10-14 4 C 0 263750 A 263750 I See footnote Common Stock 2020-10-14 4 C 0 263750 A 263750 I See footnote Common Stock 2020-10-14 4 C 0 263750 A 263750 I See footnote Series Seed Preferred Stock 2020-10-14 4 C 0 300001 D Common Stock 316501 0 I See footnote Series A Preferred Stock 2020-10-14 4 C 0 1565475 D Common Stock 1651576 0 I See footnote Convertible Promissory Note 16.15 2020-10-14 4 C 0 3000000.00 0.00 D 2022-02-20 Common Stock 185758 0 I See footnote Series Seed Preferred Stock 2020-10-14 4 C 0 250000 D Common Stock 263750 0 I See footnote Series Seed Preferred Stock 2020-10-14 4 C 0 250000 D Common Stock 263750 0 I See footnote Series Seed Preferred Stock 2020-10-14 4 C 0 250000 D Common Stock 263750 0 I See footnote Series Seed Preferred 2020-10-14 4 C 0 250000 D Common Stock 263750 0 I See footnote Each share of Series Seed Preferred Stock and Series A Preferred Stock (the "Preferred Stock") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date. By the Norbert W. & Inger A. Bischofberger Revocable Inter Vivos Trust, dtd August 29, 1994. By Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The David Michael Anthony Dynasty GST Exempt Trust dated April 29, 2020. By Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The David Michael Anthony Dynasty GST Non-Exempt Trust dated April 29, 2020. By Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The Irene Alisha Bischofberger Dynasty GST Exempt Trust dated April 29, 2020. By Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The Irene Alisha Bischofberger Dynasty GST Non-Exempt Trust dated April 29, 2020. The convertible promissory note automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. /s/ David Tanen, Attorney-in-Fact 2020-10-16